1. Home
  2. SLS vs ESOA Comparison

SLS vs ESOA Comparison

Compare SLS & ESOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLS
  • ESOA
  • Stock Information
  • Founded
  • SLS 2012
  • ESOA 2006
  • Country
  • SLS United States
  • ESOA United States
  • Employees
  • SLS N/A
  • ESOA N/A
  • Industry
  • SLS Biotechnology: Pharmaceutical Preparations
  • ESOA Water Sewer Pipeline Comm & Power Line Construction
  • Sector
  • SLS Health Care
  • ESOA Industrials
  • Exchange
  • SLS Nasdaq
  • ESOA Nasdaq
  • Market Cap
  • SLS 165.6M
  • ESOA 176.9M
  • IPO Year
  • SLS N/A
  • ESOA 2006
  • Fundamental
  • Price
  • SLS $1.66
  • ESOA $10.24
  • Analyst Decision
  • SLS Strong Buy
  • ESOA Strong Buy
  • Analyst Count
  • SLS 1
  • ESOA 1
  • Target Price
  • SLS $7.00
  • ESOA $21.00
  • AVG Volume (30 Days)
  • SLS 2.8M
  • ESOA 193.9K
  • Earning Date
  • SLS 08-12-2025
  • ESOA 08-11-2025
  • Dividend Yield
  • SLS N/A
  • ESOA 1.17%
  • EPS Growth
  • SLS N/A
  • ESOA 81.20
  • EPS
  • SLS N/A
  • ESOA 1.09
  • Revenue
  • SLS N/A
  • ESOA $367,911,284.00
  • Revenue This Year
  • SLS N/A
  • ESOA $8.96
  • Revenue Next Year
  • SLS N/A
  • ESOA $7.45
  • P/E Ratio
  • SLS N/A
  • ESOA $9.41
  • Revenue Growth
  • SLS N/A
  • ESOA 4.62
  • 52 Week Low
  • SLS $0.77
  • ESOA $6.50
  • 52 Week High
  • SLS $2.27
  • ESOA $19.83
  • Technical
  • Relative Strength Index (RSI)
  • SLS 41.18
  • ESOA 49.62
  • Support Level
  • SLS $1.75
  • ESOA $9.43
  • Resistance Level
  • SLS $1.96
  • ESOA $11.41
  • Average True Range (ATR)
  • SLS 0.12
  • ESOA 0.62
  • MACD
  • SLS -0.04
  • ESOA 0.07
  • Stochastic Oscillator
  • SLS 18.56
  • ESOA 51.25

About SLS SELLAS Life Sciences Group Inc.

SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.

About ESOA Energy Services of America Corporation

Energy Services of America Corporation is engaged in providing contracting services for energy-related companies. The company is predominantly engaged in the construction, replacement, and repair of natural gas pipelines and storage facilities for utility companies and private natural gas companies. It services the gas, petroleum, power, chemical, and automotive industries and does incidental work such as water and sewer projects. Energy Service's other services include liquid pipeline construction, pump station construction, production facility construction, water and sewer pipeline installations, various maintenance and repair services, and other services related to pipeline construction.

Share on Social Networks: